(Q50934021)

English

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tra

scientific article published in July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tra (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nitti D

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Wils J

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Sahmoud T

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Curran D

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Couvreur ML

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Lise M

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Rauschecker H

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

dos Santos JG

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Stremmel W

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Roelofsen F

10

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

33

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

1209-1215

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Intra-arterial Chemotherapy For Cancer Metastatic to Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of hepatic neoplasms via the umbilical-portal vein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant cytotoxic liver perfusion for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Planning the size and duration of a clinical trial studying the time to some critical event

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant treatment for colorectal cancer: 'state of the art'--messages from recent trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tables of the number of patients required in clinical trials using the logrank test.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900052-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00052-X

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9301444

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50934021&oldid=1584901214"